Evidence map›Paper›PMID 40586999›Full record

ArticleNeurochemical research2025

Palmitic Acid Induces Dynamic Time-Dependent Alterations in HDACs, Neuronal Chromatin Acetylation, and Gene Expression.

Saúl Santiago Rueda-Díaz, Iker Francisco Soto-Santarriaga, Karla Torres-Arciga, Valeria Melissa García-Cruz, Rodrigo González-Barrios, Manuel Flores-León, Clorinda Arias

Abstract read
In one paragraph

Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Saúl Santiago Rueda-DíazDepartamento de Medicina Genómica y Toxicología Ambiental. Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), AP 70-228, Ciudad de México, 04510, México.ORCID http://orcid.org/0000-0002-5271-0755
Iker Francisco Soto-SantarriagaDepartamento de Medicina Genómica y Toxicología Ambiental. Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), AP 70-228, Ciudad de México, 04510, México.
Karla Torres-ArcigaUnidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas (IIB), Instituto Nacional de Cancerología (INCan), Universidad Nacional Autónoma de México (UNAM), Ciudad de México, 14080, México.
Valeria Melissa García-CruzDepartamento de Medicina Genómica y Toxicología Ambiental. Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), AP 70-228, Ciudad de México, 04510, México.
Rodrigo González-BarriosUnidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas (IIB), Instituto Nacional de Cancerología (INCan), Universidad Nacional Autónoma de México (UNAM), Ciudad de México, 14080, México.
Manuel Flores-LeónDepartamento de Medicina Genómica y Toxicología Ambiental. Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), AP 70-228, Ciudad de México, 04510, México. manuel.floresleon@med.uni-goettingen.de.
Clorinda AriasDepartamento de Medicina Genómica y Toxicología Ambiental. Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), AP 70-228, Ciudad de México, 04510, México. carias@unam.mx.

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologías A1-S-9559
6 · The paper itself

Abstract

Chronic consumption of high fat diets (HFD) is a risk factor for the development of metabolic diseases such as obesity and diabetes, and it is also associated with cognitive impairment and Alzheimer´s disease. Palmitic acid (PA) is a major component of HFD, and high concentrations of this saturated fatty acid exerts pleiotropic actions in cells. The PA effects have been largely studied in peripheral tissues where is considered a driving force for the development of many metabolic diseases such as obesity, insulin resistance and Type II diabetes. In the brain, particularly in neurons, it is able to increase oxidative metabolism, induce insulin resistance, and alter gene expression. However, little is known about how PA-induced metabolic alterations may affect gene expression mechanisms in neurons. One of the most studied PA-dependent mechanisms is associated with the lipid-induced activation of the transcription factors, PPAR-γ and PGC-α, but fewer studies have analyzed the PA-dependent regulation of epigenetic mechanisms. In this study, we identified PA-linked changes in the class I histone deacetylases (HDACs) content associated with chromatin acetylation and with differential expression of the BDNF-encoding gene and the non-coding retrotransposon, LINE1 in differentiated human neuroblastoma cells.

Indexed as

ChromatinHistone DeacetylasesNeuronsPalmitic AcidAcetylationCell Line, TumorHumansChromatinHistone DeacetylasesPalmitic AcidBDNFHDACsHigh fat dietsHistone acetylationPalmitic acid

Identifiers

PMID40586999
PMCPMC12208982

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.